Something unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted Cruz calling the White House a “mafia,” and even Trump’s approval rating slipping. But veteran analyst Porter Stansberry says this isn’t really about politics at all. It’s part of a much larger shift he calls The Final Displacement — a historic economic and social realignment already impacting millions of Americans. His new documentary explains what’s driving it and how to prepare before it accelerates further.
Watch The Final Displacement to see what’s really happening behind the scenes |
|
| Tesla’s $30 trillion pivot (ad) |
Elon Musk says November 6 could "affect the future of the world"
Get ready for the biggest pivot in corporate history. Tesla insiders are preparing for a dramatic new product launch – not driverless cars – that could change everything. You're running out of time to prepare.
Our top stock idea revealed here (name and ticker revealed free). |
|
U.S. Insider Buying for Monday, October 20 | Company | Insider Name | Buy/Sell | Shares | Total Transaction | Transaction Date | Current Price | SEC Filing | MBX
MBX Biosciences | Steven L Hoerter Director | Buy | 20,000 shares @ $13.25 | $265,000.00 | 10/17/2025 | $15.30 |  | MSTR
Strategy | Jarrod M Patten Director | Buy | 11,780 shares @ $97.95 | $1,153,851.00 | 10/16/2025 | $301.91 | | MSTR
Strategy | Jarrod M Patten Director | Buy | 12,000 shares @ $96.88 | $1,162,560.00 | 10/17/2025 | $301.91 | | STRC
Sarcos Technology and Robotics | Jarrod M Patten Director | Buy | 11,780 shares @ $97.95 | $1,153,851.00 | 10/16/2025 | $98.62 | | STRC
Sarcos Technology and Robotics | Jarrod M Patten Director | Buy | 12,000 shares @ $96.88 | $1,162,560.00 | 10/17/2025 | $98.62 | |
| These 5 Stocks Are Thriving Under Trump’s Presidency (ad) |
|
U.S. Insider Selling for Monday, October 20 | Company | Insider Name | Buy/Sell | Shares | Total Transaction | Transaction Date | Current Price | SEC Filing | AREC
American Resources | Properties Ltd. Golden Major Shareholder | Sell | 980,000 shares @ $4.06 | $3,978,800.00 | 10/17/2025 | $4.23 | | AZO
AutoZone | Philip B Daniele CEO | Sell | 2,533 shares @ $4,020.88 | $10,184,889.04 | 10/17/2025 | $4,006.67 | | CRM
Salesforce | Marc Benioff CEO | Sell | 2,250 shares @ $244.64 | $550,440.00 | 10/17/2025 | $263.51 | | CRSP
CRISPR Therapeutics | Samarth Kulkarni CEO | Sell | 50,895 shares @ $67.91 | $3,456,279.45 | 10/17/2025 | $72.32 | | DC
Dakota Gold | Stephen T O'rourke Director | Sell | 50,000 shares @ $5.34 | $267,000.00 | 10/16/2025 | $4.24 | | DC
Dakota Gold | Stephen T O'rourke Director | Sell | 50,000 shares @ $4.66 | $233,000.00 | 10/20/2025 | $4.24 | | GOOG
Alphabet | Amie Thuener O'toole CAO | Sell | 2,778 shares @ $250.05 | $694,638.90 | 10/15/2025 | $251.34 | | HIMS
Hims & Hers Health | Oluyemi Okupe CFO | Sell | 11,592 shares @ $57.13 | $662,250.96 | 10/17/2025 | $49.40 | | HWC
Hancock Whitney | Michael M Achary CFO | Sell | 9,894 shares @ $54.86 | $542,784.84 | 10/17/2025 | $56.74 | | JAMF
Jamf | John Strosahl CEO | Sell | 43,650 shares @ $9.88 | $431,262.00 | 10/17/2025 | $10.55 | | JBL
Jabil | Mark T Mondello Chairman | Sell | 40,000 shares @ $207.77 | $8,310,800.00 | 10/17/2025 | $201.30 | | LVTX
LAVA Therapeutics | Gilde Healthcare Cooperatieve Major Shareholder | Sell | 1,000,000 shares @ $1.46 | $1,460,000.00 | 10/20/2015 | $1.47 | | LVTX
LAVA Therapeutics | Gilde Healthcare Cooperatieve Major Shareholder | Sell | 690,239 shares @ $1.49 | $1,028,456.11 | 10/16/2025 | $1.47 | | LVTX
LAVA Therapeutics | Gilde Healthcare Cooperatieve Major Shareholder | Sell | 1,181,131 shares @ $1.47 | $1,736,262.57 | 10/17/2025 | $1.47 | | MARA
Marathon Digital | Frederick G Thiel CEO | Sell | 27,505 shares @ $19.57 | $538,272.85 | 10/17/2025 | $20.06 | | MTSI
MACOM Technology Solutions | Robert Dennehy SVP | Sell | 4,128 shares @ $140.02 | $578,002.56 | 10/16/2025 | $139.41 | | NDSN
Nordson | Joseph P Kelley EVP | Sell | 2,300 shares @ $232.39 | $534,497.00 | 10/16/2025 | $237.73 | | NET
Cloudflare | Carl Ledbetter Director | Sell | 15,000 shares @ $210.65 | $3,159,750.00 | 10/20/2025 | $212.77 | | NET
Cloudflare | Thomas J Seifert CFO | Sell | 10,000 shares @ $211.81 | $2,118,100.00 | 10/20/2025 | $212.77 | | NVDA
NVIDIA | Jen Hsun Huang CEO | Sell | 75,000 shares @ $182.31 | $13,673,250.00 | 10/17/2025 | $181.12 | | NVDA
NVIDIA | Jen Hsun Huang CEO | Sell | 75,000 shares @ $183.38 | $13,753,500.00 | 10/20/2025 | $181.12 | | ONTF
ON24 | Sharat Sharan Insider | Sell | 32,093 shares @ $5.45 | $174,906.85 | 10/16/2025 | $5.53 | | OUST
Ouster | Megan Chung General Counsel | Sell | 5,837 shares @ $31.02 | $181,063.74 | 10/17/2025 | $31.56 | | PATH
UiPath | Daniel Dines CEO | Sell | 45,000 shares @ $15.71 | $706,950.00 | 10/20/2025 | $16.29 | | PATH
UiPath | Hitesh Ramani CAO | Sell | 10,000 shares @ $15.65 | $156,500.00 | 10/20/2025 | $16.29 | | QCOM
QUALCOMM | Akash J Palkhiwala CFO | Sell | 8,335 shares @ $166.06 | $1,384,110.10 | 10/20/2025 | $168.83 | | RYTM
Rhythm Pharmaceuticals | Joseph Shulman Insider | Sell | 14,437 shares @ $112.03 | $1,617,377.11 | 10/16/2025 | $107.15 | | SION
Sionna Therapeutics | Bruce Booth Director | Sell | 169,260 shares @ $32.35 | $5,475,561.00 | 10/16/2025 | $42.50 | | SION
Sionna Therapeutics | Bruce Booth Director | Sell | 61,124 shares @ $32.37 | $1,978,583.88 | 10/17/2025 | $42.50 | | SION
Sionna Therapeutics | Bruce Booth Director | Sell | 55,985 shares @ $32.09 | $1,796,558.65 | 10/20/2025 | $42.50 | | SNAP
Snap | Ajit Mohan Insider | Sell | 28,238 shares @ $7.83 | $221,103.54 | 10/16/2025 | $7.86 | | TEAM
Atlassian | Scott Farquhar Director | Sell | 7,665 shares @ $157.28 | $1,205,551.20 | 10/20/2025 | $168.71 | | TEAM
Atlassian | Michael Cannon-Brookes CEO | Sell | 7,665 shares @ $157.28 | $1,205,551.20 | 10/20/2025 | $168.71 | | TEAM
Atlassian | Michael Cannon-Brookes CEO | Sell | 7,665 shares @ $151.21 | $1,159,024.65 | 10/17/2025 | $168.71 | | TEAM
Atlassian | Scott Farquhar Director | Sell | 7,665 shares @ $151.21 | $1,159,024.65 | 10/17/2025 | $168.71 | | UBER
Uber Technologies | Tony West Insider | Sell | 3,125 shares @ $93.00 | $290,625.00 | 10/20/2025 | $93.07 | | UTHR
United Therapeutics | Martine A Rothblatt CEO | Sell | 4,000 shares @ $424.59 | $1,698,360.00 | 10/20/2025 | $422.53 | | UTHR
United Therapeutics | Paul A Mahon EVP | Sell | 11,000 shares @ $431.50 | $4,746,500.00 | 10/16/2025 | $422.53 | | UWMC
UWM | Ishbia Mat CEO | Sell | 596,356 shares @ $5.37 | $3,202,431.72 | 10/17/2025 | $5.66 | | UWMC
UWM | Ishbia Mat CEO | Sell | 596,356 shares @ $5.56 | $3,315,739.36 | 10/20/2025 | $5.66 | | XGN
Exagen | John Aballi CEO | Sell | 31,787 shares @ $11.82 | $375,722.34 | 10/16/2025 | $11.69 | | ZM
Zoom Communications | Aparna Bawa COO | Sell | 10,528 shares @ $79.77 | $839,818.56 | 10/16/2025 | $83.61 | |
| Shots officially fired… (ad) |
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.
Click here to watch Jeff’s urgent briefing |
|
Top Insider-Buying Stocks (Last 30 Days) | Company | Shares Purchased | Total Cost of Shares Purchased | Number of Insider Purchases | Number of Insiders Buying | Current Share Price | MarketBeat Consensus Rating | MarketBeat Consensus Price Target | Read More | | SPG Simon Property Group | 2,121 | $394,400.00 | 10 | 10 | $178.79 | Hold | $187.31 | | | ZBIO Zenas BioPharma | 923,035 | $17,628,163.00 | 7 | 6 | $26.03 | Moderate Buy | $38.33 | | | MPB Mid Penn Bancorp | 893 | $25,576.00 | 6 | 6 | $27.65 | Moderate Buy | $34.50 | | | HEI Heico | 4,048 | $987,429.00 | 6 | 6 | $315.02 | Moderate Buy | $346.09 | | | HEI.A Heico | 4,048 | $987,429.00 | 6 | 6 | $246.19 | N/A | $0.00 | | | CPSH CPS Technologies | 67,166 | $201,498.00 | 5 | 5 | $4.00 | Sell | $0.00 | | | REFI Chicago Atlantic Real Estate Finance | 51,150 | $641,414.00 | 7 | 5 | $13.04 | Moderate Buy | $20.00 | | | YORW York Water | 417 | $12,041.00 | 6 | 5 | $32.11 | Hold | $0.00 | | | STRO Sutro Biopharma | 111,754 | $89,601.00 | 5 | 5 | $1.20 | Hold | $4.47 | | | MKZR Mackenzie Realty Capital | 60,000 | $303,760.00 | 8 | 4 | $5.30 | Sell | $0.00 | |
Top Insider-Selling Stocks (Last 30 Days) | Company | Shares Sold | Total Cost of Shares Sold | Number of Insider Sales | Number of Insiders Selling | Current Share Price | MarketBeat Consensus Rating | MarketBeat Consensus Price Target | Read More | | GETY Getty Images | 127,945 | $263,669.00 | 13 | 10 | $2.01 | Reduce | $4.03 | | | FERG Ferguson | 29,264 | $6,853,349.00 | 11 | 9 | $244.77 | Moderate Buy | $240.80 | | | IONS Ionis Pharmaceuticals | 298,521 | $19,991,154.00 | 17 | 9 | $71.64 | Moderate Buy | $78.50 | | | LQDA Liquidia Technologies | 56,556 | $1,323,976.00 | 8 | 8 | $23.59 | Moderate Buy | $32.38 | | | NEUE NeueHealth | 28,245 | $190,654.00 | 8 | 8 | $6.75 | Reduce | $7.00 | | | PG Procter & Gamble | 29,582 | $4,503,268.00 | 7 | 7 | $151.61 | Moderate Buy | $171.68 | | | SAIL SailPoint | 1,026,454 | $23,056,195.00 | 19 | 7 | $22.68 | Moderate Buy | $25.64 | | | DASH DoorDash | 168,106 | $45,282,085.00 | 9 | 7 | $261.95 | Moderate Buy | $285.26 | | | CRDO Credo Technology Group | 431,464 | $63,331,698.00 | 9 | 6 | $144.17 | Buy | $131.58 | | | BLFS BioLife Solutions | 752,238 | $21,473,732.00 | 6 | 6 | $27.68 | Moderate Buy | $31.29 | |
| Thank you for subscribing to InsiderTrades.com's Insider Trades Daily Newsletter! We are committed to providing the most complete and most accurate coverage of corporate insider buying and selling activity disclosed to the Securities and Exchange Commission. InsiderTrades.com is a subsidiary of MarketBeat Media, LLC and MarketBeat.com. If you have questions about your subscription, please feel free to email MarketBeat's South Dakota based support team at contact@marketbeat.com. Unsubscribe © 2006-2025 MarketBeat Media, LLC. 345 N Reid Pl. #620, Sioux Falls, S.D. 57103-7078. United States. . From Our Partners: Nvidia CEO Makes First Ever Tesla Announcement (From Brownstone Research) | |
